What AI says about Allogene Therapeutics

Allogene Therapeutics is developing AlloCAR T products, which are allogeneic CAR T cell therapies designed to treat blood cancers, solid tumors, and autoimmune diseases. Their platform aims to provide an off-the-shelf, scalable treatment with the potential to treat over 100 patients from a single manufacturing run.